Search Prime Grants

HT94252310546

Project Grant

Overview

Grant Description
Rna therapeutics for infectious diseases: viral hemorrhagic fever.
Awardee
University Of Massachusetts Medical School
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Worcester, Massachusetts 016550002 United States
Geographic Scope
Single Zip Code
Related Opportunity
HT942523SBAA1
University Of Massachusetts Medical School was awarded RNA Therapeutics Viral Hemorrhagic Fever: Advancing Treatment Prevention Project Grant HT94252310546 worth $7,349,780 from Defense Health Agency in September 2023 with work to be completed primarily in Worcester Massachusetts United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 6/26/23

Period of Performance
9/1/23
Start Date
8/31/27
End Date
55.0% Complete

Funding Split
$7.3M
Federal Obligation
$0.0
Non-Federal Obligation
$7.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310546

Subgrant Awards

Disclosed subgrants for HT94252310546

Additional Detail

Award ID FAIN
HT94252310546
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
State Government
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
MQE2JHHJW9Q8
Awardee CAGE
6R004
Performance District
02
Senators
Edward Markey
Elizabeth Warren
Representative
James McGovern

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Research, Development, Test, and Evaluation, Army (021-2040) Department of Defense-Military Research and development contracts (25.5) $7,349,780 100%
Modified: 6/26/23